Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 ICON Central Labs Doubles Storage Capacity | Contract Pharma

What are you searching for?

Sign in
Breaking News

ICON Central Labs Doubles Storage Capacity

Expands biospecimen management

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

ICON has expanded the biorepository capacity in its central laboratory in Farmingdale, NY, doubling its sample storage capacity globally and supporting long-term sample storage for clinical trials.
 
The biorepository facilities store a range of specimens, including plasma, serum, whole blood, RNA, DNA, peripheral blood mononuclear cell (PBMC), urine and tissue at frozen storage conditions of -20°C, -70°C, -80°C, and -150°C liquid nitrogen, across the entire lifecycle from collection and processing to final disposal.
 
“We’re investing in this expansion to meet our sponsor’s biorepository needs and because we believe that long-term preservation of samples is essential for the future of drug development, in particular for personalized medicine strategies that foresee an ever-increasing need for downstream analysis,” said Tom O’Leary, president, ICON Central Laboratories. “The co-location of our biorepository services with our central labs in North America, Europe, Singapore and India is critical, as it allows for future analysis while minimizing the risks and costs associated with transporting samples.”

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics